Tweedy Browne's JAZZ Position Overview
Tweedy Browne (via Tweedy, Browne Co LLC) currently holds 59,279 shares of Jazz Pharmaceuticals plc (JAZZ) worth $13.72 M, representing 1.12% of the portfolio. First purchased in 2026-Q1, this short-term holding has been held for 3 quarters.
Based on 13F filings, Tweedy Browne has maintained this position in JAZZ for several quarters, showing initial confidence in the investment. Largest reduction occurred in Q3 2026, reducing 870 shares.
Analysis based on 13F filings available since 2013 Q2
Tweedy Browne's Jazz Pharmaceuticals plc (JAZZ) Holding Value Over Time
Track share changes against reported price movement
Quarterly Jazz Pharmaceuticals plc (JAZZ) Trades by Tweedy Browne
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | -870 | Reduce 1.45% | 59,279 | $231.52 |
| Q2 2026 | -60 | Reduce 0.10% | 60,149 | $240.97 |
| Q1 2026 | +60,209 | New Buy | 60,209 | $189.05 |
Tweedy Browne's Jazz Pharmaceuticals plc Investment FAQs
Tweedy Browne first purchased Jazz Pharmaceuticals plc (JAZZ) in Q1 2026, acquiring 60,209 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Tweedy Browne has held Jazz Pharmaceuticals plc (JAZZ) for 3 quarters since Q1 2026.
Tweedy Browne's largest addition to Jazz Pharmaceuticals plc (JAZZ) was in Q1 2026, adding 60,209 shares worth $11.38 M.
According to the latest 13F filing for Q3 2026, Tweedy Browne's firm, Tweedy, Browne Co LLC, owns 59,279 shares of Jazz Pharmaceuticals plc (JAZZ), valued at approximately $13.72 M.
As of the Q3 2026 filing, Jazz Pharmaceuticals plc (JAZZ) represents approximately 1.12% of Tweedy Browne's publicly disclosed stock portfolio, making it one of their key holdings.
Tweedy Browne's peak holding in Jazz Pharmaceuticals plc (JAZZ) was 60,209 shares, as reported at the end of Q1 2026.